Clinical trials are set to begin on the use of MDMA, more commonly known as ecstasy, and its effectiveness in treating PTSD. The US. Food and Drug Administration granted permission for phase three, clinical trials of MDMA this past Wednesday. MDMA could be available as a PTSD treatment by 2021 if the trial is successful and researches application to speed up the approval process is granted.
For the full story click here